Mouse Ripor2 Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Ripor2 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Ripor2 Knockout Project (CRISPR/Cas9) Objective: To create a Ripor2 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Ripor2 gene (NCBI Reference Sequence: NM_029679.2 ; Ensembl: ENSMUSG00000036006 ) is located on Mouse chromosome 13. 23 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 23 (Transcript: ENSMUST00000110384). Exon 2~7 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Homozygous knockout mice are deaf. The gene product is expressed in the basal region of cochlear hair cell stereocillia, which are disorganized and malformed in null mice. Exon 2 starts from about 1.55% of the coding region. Exon 2~7 covers 18.24% of the coding region. The size of effective KO region: ~7914 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 23 Legends Exon of mouse Ripor2 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 7 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Page 3 of 9 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(27.25% 545) | C(20.95% 419) | T(27.3% 546) | G(24.5% 490) Note: The 2000 bp section upstream of Exon 2 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(27.6% 552) | C(23.3% 466) | T(24.25% 485) | G(24.85% 497) Note: The 2000 bp section downstream of Exon 7 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr13 + 24667961 24669960 2000 browser details YourSeq 258 19 369 2000 89.2% chr13 - 24666179 24666519 341 browser details YourSeq 101 1325 1436 2000 99.1% chr10 - 73797011 73797122 112 browser details YourSeq 88 1310 1437 2000 92.9% chr13 + 114922791 114922917 127 browser details YourSeq 77 1303 1405 2000 94.3% chr1 + 97778154 97778256 103 browser details YourSeq 74 1352 1435 2000 94.1% chr1 - 153668687 153668770 84 browser details YourSeq 65 1310 1409 2000 83.4% chr11 - 36018962 36019043 82 browser details YourSeq 54 1303 1378 2000 81.1% chr9 + 82688441 82688499 59 browser details YourSeq 54 76 159 2000 86.6% chr10 + 62361888 62361970 83 browser details YourSeq 50 41 146 2000 77.6% chr1 + 36695828 36695916 89 browser details YourSeq 46 1393 1438 2000 100.0% chr14 - 32777396 32777441 46 browser details YourSeq 42 127 260 2000 93.8% chr11 - 84442062 84463723 21662 browser details YourSeq 42 1301 1369 2000 76.4% chr13 + 33184422 33184484 63 browser details YourSeq 37 106 157 2000 97.5% chr7 - 112357105 112357185 81 browser details YourSeq 37 119 157 2000 92.2% chr13 + 95286150 95286187 38 browser details YourSeq 36 123 188 2000 82.2% chr7 - 112625051 112625117 67 browser details YourSeq 36 1303 1351 2000 87.5% chr11 - 100956611 100956657 47 browser details YourSeq 36 1403 1438 2000 100.0% chr15 + 25551530 25551565 36 browser details YourSeq 35 119 157 2000 89.5% chr18 + 14703972 14704009 38 browser details YourSeq 35 131 206 2000 92.7% chr15 + 84880654 84880730 77 Note: The 2000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr13 + 24677875 24679874 2000 browser details YourSeq 107 378 1091 2000 86.3% chr11 - 99336187 99766684 430498 browser details YourSeq 89 358 453 2000 96.9% chr1 - 130576377 130576480 104 browser details YourSeq 85 379 952 2000 93.3% chr10 + 13884363 14012606 128244 browser details YourSeq 64 862 974 2000 84.8% chr7 + 113034395 113034505 111 browser details YourSeq 60 384 452 2000 94.3% chr12 + 18072645 18072714 70 browser details YourSeq 59 378 448 2000 96.9% chr10 - 35461214 35461289 76 browser details YourSeq 55 392 452 2000 96.8% chr7 - 43960529 43960608 80 browser details YourSeq 55 387 453 2000 88.4% chr1 + 97903527 97903589 63 browser details YourSeq 53 1024 1091 2000 89.8% chr6 + 128266830 128266898 69 browser details YourSeq 53 1027 1130 2000 72.3% chr10 + 43281953 43282029 77 browser details YourSeq 51 1028 1099 2000 86.2% chr2 + 169105954 169106042 89 browser details YourSeq 51 387 450 2000 84.3% chr12 + 51327496 51327553 58 browser details YourSeq 50 1024 1091 2000 84.9% chr11 - 4924285 4924351 67 browser details YourSeq 50 1030 1089 2000 91.7% chr14 + 87116992 87117051 60 browser details YourSeq 49 1024 1091 2000 86.6% chr11 + 80350341 80350409 69 browser details YourSeq 48 1024 1091 2000 85.3% chr5 - 146453015 146453082 68 browser details YourSeq 48 1026 1091 2000 86.4% chr12 - 55678017 55678082 66 browser details YourSeq 48 1026 1093 2000 85.3% chr10 - 31612225 31612292 68 browser details YourSeq 48 1028 1091 2000 87.5% chr1 + 133523290 133523353 64 Note: The 2000 bp section downstream of Exon 7 is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 https://www.alphaknockout.com Gene and protein information: Ripor2 RHO family interacting cell polarization regulator 2 [ Mus musculus (house mouse) ] Gene ID: 193385, updated on 26-Jun-2020 Gene summary Official Symbol Ripor2 provided by MGI Official Full Name RHO family interacting cell polarization regulator 2 provided by MGI Primary source MGI:MGI:2444879 See related Ensembl:ENSMUSG00000036006 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Fam65b Expression Broad expression in spleen adult (RPKM 12.9), CNS E18 (RPKM 6.6) and 18 other tissues See more Orthologs human all Genomic context Location: 13; 13 A3.1 See Ripor2 in Genome Data Viewer Exon count: 30 Annotation release Status Assembly Chr Location 108.20200622 current GRCm38.p6 (GCF_000001635.26) 13 NC_000079.6 (24501524..24733806) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 13 NC_000079.5 (24706479..24825675) Chromosome 13 - NC_000079.6 Page 6 of 9 https://www.alphaknockout.com Transcript information: This gene has 14 transcripts Gene: Ripor2 ENSMUSG00000036006 Description RHO family interacting cell polarization regulator 2 [Source:MGI Symbol;Acc:MGI:2444879] Gene Synonyms 1700108N18Rik, 6330500D04Rik, E430013J17Rik, Fam65b Location Chromosome 13: 24,501,525-24,733,816 forward strand. GRCm38:CM001006.2 About this gene This gene has 14 transcripts (splice variants), 280 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 8 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Ripor2- ENSMUST00000110384.8 5608 1078aa ENSMUSP00000106013.2 Protein coding CCDS36622 Q80U16 TSL:1 205 GENCODE basic APPRIS ALT2 Ripor2- ENSMUST00000110383.7 5476 1053aa ENSMUSP00000106012.1 Protein coding CCDS70438 A6PW28 TSL:1 204 GENCODE basic APPRIS ALT2 Ripor2- ENSMUST00000038477.6 3371 672aa ENSMUSP00000043663.6 Protein coding CCDS36623 Q80U16 TSL:1 201 GENCODE basic APPRIS ALT2 Ripor2- ENSMUST00000091694.9 3142 633aa ENSMUSP00000089286.3 Protein coding CCDS26377 Q80U16 TSL:1 203 GENCODE basic APPRIS P3 Ripor2- ENSMUST00000058009.15 2550 389aa ENSMUSP00000051342.9 Protein coding - Q80U16 TSL:2 202 GENCODE basic APPRIS ALT2 Ripor2- ENSMUST00000238974.1 2364 639aa ENSMUSP00000159186.1 Protein coding - A0A5F8MPY8 GENCODE 214 basic APPRIS ALT2 Ripor2- ENSMUST00000132689.7 3261 40aa ENSMUSP00000115689.1 Nonsense mediated - F2Z3V4 TSL:1 206 decay Ripor2- ENSMUST00000134370.7 2342 No - Retained intron - - TSL:2 207 protein Ripor2- ENSMUST00000175986.1 2004 No - Retained intron - - TSL:1 209 protein Ripor2- ENSMUST00000138547.7 1350 No - Retained intron - - TSL:1 208 protein Ripor2- ENSMUST00000177489.1 760 No - Retained intron - - TSL:5 213 protein Ripor2- ENSMUST00000177298.7 665 No - Retained intron - - TSL:2 212 protein Ripor2- ENSMUST00000177174.1 649 No - Retained intron - - TSL:3 211 protein Ripor2- ENSMUST00000176303.1 546 No - Retained intron - - TSL:5 210 protein Page 7 of 9 https://www.alphaknockout.com 252.29 kb Forward strand 24.5Mb 24.6Mb 24.7Mb Genes (Comprehensive set... Ripor2-214 >protein coding Ripor2-213 >retained intron Ripor2-204 >protein coding Ripor2-203 >protein coding Armh2-201 >protein coding Ripor2-207 >retained intron Ripor2-206 >nonsense mediated decay Ripor2-205 >protein coding Ripor2-212 >retained intronRipor2-211 >retained intron Ripor2-202 >protein coding Ripor2-201 >protein coding Ripor2-208 >retained intron Ripor2-210 >retained intron Ripor2-209 >retained intron Contigs AL589744.18 > AL591851.12 > AL513014.9 > AL589699.4 > Genes < Gm11346-204processed transcript (Comprehensive set..
Recommended publications
  • Psychostimulant-Regulated Plasticity in Interneurons of the Nucleus Accumbens
    Psychostimulant-Regulated Plasticity in Interneurons of the Nucleus Accumbens by David A. Gallegos Department of Neurobiology Duke University Date:_______________________ Approved: ___________________________ Anne E. West, Supervisor ___________________________ Jorg Grandl ___________________________ Debra Silver ___________________________ Gregory Crawford ___________________________ Hiro Matsunami Psychostimulant-Regulated Epigenetic Plasticity in Interneurons of the Nucleus Accumbens submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Neurobiology in the Graduate School of Duke University 2019 ABSTRACT Psychostimulant-Regulated Epigenetic Plasticity in Interneurons of the Nucleus Accumbens by David A. Gallegos Department of Neurobiology Duke University Date:_______________________ Approved: ___________________________ Anne E. West, Supervisor ___________________________ Jorg Grandl ___________________________ Debra Silver ___________________________ Gregory Crawford ___________________________ Hiro Matsunami An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Neurobiology in the Graduate School of Duke University 2019 Copyright by David Andres Gallegos 2019 Abstract Exposure to psychostimulant drugs of abuse exerts lasting influences on brain function via the regulation of immediate and persistent gene transcription. These changes in gene transcription drive the development of addictive-like
    [Show full text]
  • CSE642 Final Version
    Eindhoven University of Technology MASTER Dimensionality reduction of gene expression data Arts, S. Award date: 2018 Link to publication Disclaimer This document contains a student thesis (bachelor's or master's), as authored by a student at Eindhoven University of Technology. Student theses are made available in the TU/e repository upon obtaining the required degree. The grade received is not published on the document as presented in the repository. The required complexity or quality of research of student theses may vary by program, and the required minimum study period may vary in duration. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain Eindhoven University of Technology MASTER THESIS Dimensionality Reduction of Gene Expression Data Author: S. (Sako) Arts Daily Supervisor: dr. V. (Vlado) Menkovski Graduation Committee: dr. V. (Vlado) Menkovski dr. D.C. (Decebal) Mocanu dr. N. (Nikolay) Yakovets May 16, 2018 v1.0 Abstract The focus of this thesis is dimensionality reduction of gene expression data. I propose and test a framework that deploys linear prediction algorithms resulting in a reduced set of selected genes relevant to a specified case. Abstract In cancer research there is a large need to automate parts of the process of diagnosis, this is mainly to reduce cost, make it faster and more accurate.
    [Show full text]
  • GWAS for Meat and Carcass Traits
    G3: Genes|Genomes|Genetics Early Online, published on July 11, 2019 as doi:10.1534/g3.119.400452 GWAS for meat and carcass traits using imputed sequence level genotypes in pooled F2- designs in pigs Clemens Falker-Gieske,*,1,2 Iulia Blaj,†,2 Siegfried Preuß,‡ Jörn Bennewitz,‡ Georg Thaller,† Jens Tetens*,§ *Department of Animal Sciences, Georg-August-University, 37077 Göttingen, Germany. †Institute of Animal Breeding and Husbandry, Kiel University, 24118 Kiel, Germany. ‡Institute of Animal Husbandry and Breeding, University of Hohenheim, 70599 Stuttgart, Germany. §Center for Integrated Breeding Research, Georg-August-University, 37077 Göttingen, Germany. 1 © The Author(s) 2013. Published by the Genetics Society of America. Running title: Sequence level GWAS in pooled F2 pigs Keywords Genome wide association study Whole genome sequencing Imputation Meat, carcass, and production traits Variant calling 1Corresponding author: Clemens Falker-Gieske, Georg-August-University Goettingen, Department of Animal Sciences, Division Functional Breeding, Burckhardtweg 2, 37077 Goettingen, (+49) 551-39-23669 2contributed equally. 2 ABSTRACT In order to gain insight into the genetic architecture of economically important traits in pigs and to derive suitable genetic markers to improve these traits in breeding programs, many studies have been conducted to map quantitative trait loci. Shortcomings of these studies were low mapping resolution, large confidence intervals for quantitative trait loci-positions and large linkage disequilibrium blocks. Here, we overcome these shortcomings by pooling four large F2 designs to produce smaller linkage disequilibrium blocks and by resequencing the founder generation at high coverage and the F1 generation at low coverage for subsequent imputation of the F2 generation to whole genome sequencing marker density.
    [Show full text]
  • SUPPLEMENTARY METHODS DNA Sequencing and Variant
    Supplementary material J Med Genet SUPPLEMENTARY METHODS DNA sequencing and variant identification Genomic DNA was isolated from peripheral blood lymphocytes following standard procedures. Subsequently, exome enrichment was performed using the Agilent SureSelect Human All Exome V5 kit according to the manufacturer’s protocols. Exome sequencing was performed on an Illumina HiSeq system by BGI Europe (Copenhagen, Denmark). Read mapping along the hg19 reference genome (GRCh37/hg19) and variant calling were performed using BWA V.0.78(1) and GATK HaplotypeCaller V.3.3(2). A coverage of >20 reads was reached for 85.1% to 97.8% of the enriched regions. For variant annotation an in-house developed annotation and variant evaluation pipeline was used. For sequencing data of family W97-056, CNV detection was performed using CoNIFER V.0.2.2.(3) Genome sequencing was performed by BGI (Hong Kong, China) on a BGISeq500 using a 2x 100 bp paired end module, with a minimal median coverage of 30-fold per genome. Structural variants were called using Manta V.1.1.0(4) and CNVs using Control-FREEC.(5) Variants were validated and visualized using the IGV Software (V.2.4).(6) In the index case of family W08-1421, targeted DNA sequencing was performed using MIP sequencing.(7) MIPs were designed covering exons and exon-intron boundaries of a panel of 89 HL genes (Supplementary Table 6). Sequencing and data analysis were performed as previously described.(8) For each targeted region, an average coverage of 420 reads was obtained. A coverage of >20 reads was reached for 85.4% of the MIPs.
    [Show full text]
  • Meta-Analysis of Gene Signatures and Key Pathways Indicates
    www.nature.com/scientificreports OPEN Meta‑analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo‑resistance in AML Parastoo Modarres1, Farzaneh Mohamadi Farsani1,3, Amir Abas Nekouie2 & Sadeq Vallian1* The pathways and robust deregulated gene signatures involved in AML chemo‑resistance are not fully understood. Multiple subgroups of AMLs which are under treatment of various regimens seem to have similar regulatory gene(s) or pathway(s) related to their chemo‑resistance phenotype. In this study using gene set enrichment approach, deregulated genes and pathways associated with relapse after chemotherapy were investigated in AML samples. Five AML libraries compiled from GEO and ArrayExpress repositories were used to identify signifcantly diferentially expressed genes between chemo‑resistance and chemo‑sensitive groups. Functional and pathway enrichment analysis of diferentially expressed genes was performed to assess molecular mechanisms related to AML chemotherapeutic resistance. A total of 34 genes selected to be diferentially expressed in the chemo‑ resistance compared to the chemo‑sensitive group. Among the genes selected, c-Jun, AKT3, ARAP3, GABBR1, PELI2 and SORT1 are involved in neurotrophin, estrogen, cAMP and Toll‑like receptor signaling pathways. All these pathways are located upstream and regulate JNK signaling pathway which functions as a key regulator of cellular apoptosis. Our expression data are in favor of suppression of JNK pathway, which could induce pro‑apoptotic gene expression as well as down regulation of survival factors, introducing this pathway as a key regulator of drug‑resistance development in AML. Acute myeloid leukemia (AML) is one of the most aggressive, life-threatening hematological malignancies char- acterized by uncontrolled proliferation of abnormal diferentiated and nonfunctional myeloid precursor cells1.
    [Show full text]
  • Explorative Bioinformatic Analysis of Cardiomyocytes in 2D &3D in Vitro Culture System
    EXPLORATIVE BIOINFORMATIC ANALYSIS OF CARDIOMYOCYTES IN 2D &3D IN VITRO CULTURE SYSTEM VERSION 2 Master Degree Project in Bioscience One years Level, 60 ECTS Sruthy Janardanan [email protected] Supervisor: Jane Synnergren [email protected] Examiner: Sanja Jurcevic [email protected] Abstract The in vitro cell culture models of human pluripotent stem cells (hPSC)-derived cardiomyocytes (CMs) have gained a predominant value in the field of drug discovery and is considered an attractive tool for cardiovascular disease modellings. However, despite several reports of different protocols for the hPSC-differentiation into CMs, the development of an efficient, controlled and reproducible 3D differentiation remains challenging. The main aim of this research study was to understand the changes in the gene expression as an impact of spatial orientation of hPSC-derived CMs in 2D(two-dimensional) and 3D(three-dimensional) culture conditions and to identify the topologically important Hub and Hub-Bottleneck proteins using centrality measures to gain new knowledge for standardizing the pre-clinical models for the regeneration of CMs. The above-mentioned aim was achieved through an extensive bioinformatic analysis on the list of differentially expressed genes (DEGs) identified from RNA-sequencing (RNA-Seq). Functional annotation analysis of the DEGs from both 2D and 3D was performed using Cytoscape plug-in ClueGO. Followed by the topological analysis of the protein-protein interaction network (PPIN) using two centrality parameters; Degree and Betweeness in Cytoscape plug-in CenTiScaPe. The results obtained revealed that compared to 2D, DEGs in 3D are primarily associated with cell signalling suggesting the interaction between cells as an impact of the 3D microenvironment and topological analysis revealed 32 and 39 proteins as Hub and Hub-Bottleneck proteins, respectively in 3D indicating the possibility of utilizing those identified genes and their corresponding proteins as cardiac disease biomarkers in future by further research.
    [Show full text]
  • An RNA Switch of a Large Exon of Ninein Is Regulated by the Neural Stem Cell Specific-RNA Binding Protein, Qki5
    International Journal of Molecular Sciences Article An RNA Switch of a Large Exon of Ninein Is Regulated by the Neural Stem Cell Specific-RNA Binding Protein, Qki5 Yoshika Hayakawa-Yano and Masato Yano * Division of Neurobiology and Anatomy, Graduate School of Medical and Dental Sciences, Niigata University, 757, Ichibancho, Asahimachidori, Chuo-ku, Niigata, Niigata 951-8510, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-25-227-2054 Received: 10 January 2019; Accepted: 21 February 2019; Published: 26 February 2019 Abstract: A set of tissue-specific splicing factors are thought to govern alternative splicing events during neural progenitor cell (NPC)-to-neuron transition by regulating neuron-specific exons. Here, we propose one such factor, RNA-binding protein Quaking 5 (Qki5), which is specifically expressed in the early embryonic neural stem cells. We performed mRNA-SEQ (Sequence) analysis using mRNAs obtained by developing cerebral cortices in Qk (Quaking) conditional knockout (cKO) mice. As expected, we found a large number of alternative splicing changes between control and conditional knockouts relative to changes in transcript levels. DAVID (The Database for Annotation, Visualization and Integrated Discovery) and Metascape analyses suggested that the affected spliced genes are involved in axon development and microtubule-based processes. Among these, the mRNA coding for the Ninein protein is listed as one of Qki protein-dependent alternative splicing targets. Interestingly, this exon encodes a very long polypeptide (2121 nt), and has been previously defined as a dynamic RNA switch during the NPC-to-neuron transition. Additionally, we validated that the regulation of this large exon is consistent with the Qki5-dependent alternative exon inclusion mode suggested by our previous Qki5 HITS-CLIP (high throughput sequencing-cross linking immunoprecipitation) analysis.
    [Show full text]
  • Ernas and Superenhancer Lncrnas Are Functional in Human Prostate Cancer
    Hindawi Disease Markers Volume 2020, Article ID 8847986, 17 pages https://doi.org/10.1155/2020/8847986 Research Article eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer Xiaona Zhang,1,2,3 Panpan Pang,2,3,4 Min Jiang,1,2,3 Qunfa Cao,2,3 Huili Li,2,3 Yi Xu,5 Yao Li ,4 Xue Chen ,1 and Junsong Han 2,3 1Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China 2National Engineering Center for Biochip at Shanghai, Shanghai, China 3Shanghai Biochip Corporation, Shanghai, China 4Shanghai Engineering Research Center of Industrial Microorganisms, School of Life Science, Fudan University, Shanghai, China 5Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine, Shanghai, China Correspondence should be addressed to Yao Li; [email protected], Xue Chen; [email protected], and Junsong Han; [email protected] Received 23 June 2020; Revised 27 July 2020; Accepted 14 August 2020; Published 24 September 2020 Academic Editor: Mingjun Shi Copyright © 2020 Xiaona Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Prostate cancer (PCa) is one of the most commonly diagnosed cancers in males worldwide. lncRNAs (long noncoding RNAs) play a significant role in the occurrence and development of PCa. eRNAs (enhancer RNAs) and SE-lncRNAs (superenhancer lncRNAs) are important elements of lncRNAs, but the role of eRNAs and SE-lncRNAs in PCa remains largely unclear. In this work, we identified 681 eRNAs and 292 SE-lncRNAs that were expressed differentially in PCa using a microarray.
    [Show full text]
  • Somatic Mutations in Early Onset Luminal Breast Cancer
    www.oncotarget.com Oncotarget, 2018, Vol. 9, (No. 32), pp: 22460-22479 Research Paper Somatic mutations in early onset luminal breast cancer Giselly Encinas1,*, Veronica Y. Sabelnykova2,*, Eduardo Carneiro de Lyra3, Maria Lucia Hirata Katayama1, Simone Maistro1, Pedro Wilson Mompean de Vasconcellos Valle1, Gláucia Fernanda de Lima Pereira1, Lívia Munhoz Rodrigues1, Pedro Adolpho de Menezes Pacheco Serio1, Ana Carolina Ribeiro Chaves de Gouvêa1, Felipe Correa Geyer1, Ricardo Alves Basso3, Fátima Solange Pasini1, Maria del Pilar Esteves Diz1, Maria Mitzi Brentani1, João Carlos Guedes Sampaio Góes3, Roger Chammas1, Paul C. Boutros2,4,5 and Maria Aparecida Azevedo Koike Folgueira1 1Instituto do Cancer do Estado de Sao Paulo, Departamento de Radiologia e Oncologia, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil 2Ontario Institute for Cancer Research, Toronto, Canada 3Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil 4Department of Medical Biophysics, University of Toronto, Toronto, Canada 5Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada *These authors have contributed equally to this work Correspondence to: Maria Aparecida Azevedo Koike Folgueira, email: [email protected] Keywords: breast cancer; young patients; somatic mutation; germline mutation; luminal subtype Received: September 26, 2017 Accepted: March 06, 2018 Published: April 27, 2018 Copyright: Encinas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Breast cancer arising in very young patients may be biologically distinct; however, these tumors have been less well studied.
    [Show full text]
  • Effective Prediction of Prostate Cancer Recurrence Through the IQGAP1 Network
    cancers Article Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network Yan Gu 1,2,3, Xiaozeng Lin 1,2,3, Anil Kapoor 2,3,4 , Taosha Li 5, Pierre Major 6 and Damu Tang 1,2,3,* 1 Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada; [email protected] (Y.G.); [email protected] (X.L.) 2 Urological Cancer Center for Research and Innovation (UCCRI), St Joseph’s Hospital, Hamilton, ON L8N 4A6, Canada; [email protected] 3 The Research Institute of St Joe’s Hamilton, St Joseph’s Hospital, Hamilton, ON L8N 4A6, Canada 4 Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada 5 Life-Tech Industry Alliance, Shenzhen 518000, China; [email protected] 6 Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-905-522-1155 (ext. 35168) Simple Summary: Prostate cancer (PC) is a leading cause of cancer death in men in the developed countries. PC mortality is related to tumor relapse following curative therapy to primary tumors. It is thus essential to effectively assess the recurrence risk for personalized patient management. However, the current assessment capacity remains insufficient. We examined tumors produced in animals and samples derived from more than 1100 patients. A unique set of gene expression was observed following PC progression and a multigene panel consisting of 27 genes (Sig27gene) was constructed. Sig27gene is novel and robustly predicts PC relapse in two independent patient populations (n = 492 and n = 140) at p < 2 × 10−16. Sig27gene remains an independent risk factor of PC recurrence after adjusting for multiple clinical features.
    [Show full text]
  • Gene Expression Responses of Larval Gopher (Sebastes Carnatus) and Blue (S
    California State University, Monterey Bay Digital Commons @ CSUMB Capstone Projects and Master's Theses Capstone Projects and Master's Theses Fall 2020 Gene Expression Responses of Larval Gopher (Sebastes carnatus) and Blue (S. mystinus) Rockfish ot Ocean Acidification and Hypoxia Jacoby Baker Follow this and additional works at: https://digitalcommons.csumb.edu/caps_thes_all This Master's Thesis (Open Access) is brought to you for free and open access by the Capstone Projects and Master's Theses at Digital Commons @ CSUMB. It has been accepted for inclusion in Capstone Projects and Master's Theses by an authorized administrator of Digital Commons @ CSUMB. For more information, please contact [email protected]. GENE EXPRESSION RESPONSES OF LARVAL GOPHER (SEBASTES CARNATUS) AND BLUE (S. MYSTINUS) ROCKFISH TO OCEAN ACIDIFICATION AND HYPOXIA A Thesis Presented to the Faculty of Moss Landing Marine Laboratories California State University Monterey Bay In Partial Fulfillment of the Requirements for the Degree Master of Science in Marine Science by Jacoby Baker Fall 2020 CALIFORNIA STATE UNIVERSITY MONTEREY BAY The Undersigned Faculty Committee Approves the Thesis of Jacoby Baker: GENE EXPRESSION RESPONSES OF LARVAL GOPHER (SEBASTES CARNATUS) AND BLUE (S. MYSTINUS) ROCKFISH TO OCEAN ACIDIFICATION AND HYPOXIA Scott Hamilton, Chair Moss Landing Marine Laboratories Cheryl Logan, Primary Research Advisor California State Monterey Bay Jonathan Geller Moss Landing Marine Laboratories Nathaniel Jue California State Monterey Bay Daniel Shapiro, Interim Dean Associate VP for Academic Programs and Dean of Undergraduate and Graduate Studies 12/11/2020 Approval Date iii Copyright © 2020 by Jacoby Baker All Rights Reserved iv ABSTRACT Gene Expression Responses of Larval Gopher (Sebastes carnatus) and Blue (S.
    [Show full text]
  • Thousands of Cpgs Show DNA Methylation Differences in ACPA-Positive Individuals
    G C A T T A C G G C A T genes Article Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals Yixiao Zeng 1,2, Kaiqiong Zhao 2,3, Kathleen Oros Klein 2, Xiaojian Shao 4, Marvin J. Fritzler 5, Marie Hudson 2,6,7, Inés Colmegna 6,8, Tomi Pastinen 9,10, Sasha Bernatsky 6,8 and Celia M. T. Greenwood 1,2,3,9,11,* 1 PhD Program in Quantitative Life Sciences, Interfaculty Studies, McGill University, Montréal, QC H3A 1E3, Canada; [email protected] 2 Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada; [email protected] (K.Z.); [email protected] (K.O.K.); [email protected] (M.H.) 3 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC H3A 1A2, Canada 4 Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada; [email protected] 5 Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada; [email protected] 6 Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada; [email protected] (I.C.); [email protected] (S.B.) 7 Division of Rheumatology, Jewish General Hospital, Montréal, QC H3T 1E2, Canada 8 Division of Rheumatology, McGill University, Montréal, QC H3G 1A4, Canada 9 Department of Human Genetics, McGill University, Montréal, QC H3A 0C7, Canada; [email protected] 10 Center for Pediatric Genomic Medicine, Children’s Mercy, Kansas City, MO 64108, USA 11 Gerald Bronfman Department of Oncology, McGill University, Montréal, QC H4A 3T2, Canada * Correspondence: [email protected] Citation: Zeng, Y.; Zhao, K.; Oros Abstract: High levels of anti-citrullinated protein antibodies (ACPA) are often observed prior to Klein, K.; Shao, X.; Fritzler, M.J.; Hudson, M.; Colmegna, I.; Pastinen, a diagnosis of rheumatoid arthritis (RA).
    [Show full text]